Author's Reply to: Osimertinib and jaw osteonecrosis? A case report

Int J Cancer. 2019 Oct 1;145(7):2006-2007. doi: 10.1002/ijc.32398. Epub 2019 May 10.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Acrylamides
  • Aniline Compounds
  • ErbB Receptors
  • Humans
  • Jaw Diseases*
  • Osteonecrosis*

Substances

  • Acrylamides
  • Aniline Compounds
  • osimertinib
  • EGFR protein, human
  • ErbB Receptors